Assura (LON:AGR - Get Free Report)'s stock had its "buy" rating reiterated by analysts at Peel Hunt in a note issued to investors on Tuesday,Digital Look reports. They currently have a GBX 60 target price on the real estate investment trust's stock. Peel Hunt's price target would suggest a potential upside of 27.39% from the company's previous close.
Assura Stock Up 0.2%
Shares of LON:AGR opened at GBX 47.10 on Tuesday. The stock has a market cap of £1.53 billion, a price-to-earnings ratio of 888.68, a PEG ratio of 3.60 and a beta of 0.37. The company has a quick ratio of 2.84, a current ratio of 0.89 and a debt-to-equity ratio of 85.05. Assura has a 12-month low of GBX 35.24 and a 12-month high of GBX 50.95. The business's 50 day moving average is GBX 48.14 and its 200 day moving average is GBX 48.48.
Assura (LON:AGR - Get Free Report) last announced its earnings results on Monday, July 21st. The real estate investment trust reported GBX 3.50 earnings per share (EPS) for the quarter. Assura had a negative return on equity of 1.92% and a negative net margin of 18.09%. On average, sell-side analysts forecast that Assura will post 3.5830389 earnings per share for the current fiscal year.
Insider Transactions at Assura
In related news, insider Ed Smith sold 116,163 shares of the business's stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of GBX 49, for a total transaction of £56,919.87. Also, insider Jayne Cottam sold 1,017,587 shares of the business's stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of GBX 50, for a total value of £508,793.50. In the last three months, insiders have bought 2,540 shares of company stock valued at $125,674 and have sold 5,182,149 shares valued at $258,872,495. 0.93% of the stock is currently owned by company insiders.
Assura Company Profile
(
Get Free Report)
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Assura, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Assura wasn't on the list.
While Assura currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.